PubMed

Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide.

Fakhouri F, Teixeira L, Delarue R, Grünfeld JP, Veyradier A.

Ann Intern Med. 2004 Feb 17;140(4):314-5. No abstract available. Erratum in: Ann Intern Med. 2004 May 4;140(9):767. PMID: 14970167 [PubMed - indexed for MEDLINE]Related articlesFree article

Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community.

George JN, Vesely SK.

Ann Intern Med. 2003 Jan 21;138(2):152-3. No abstract available. PMID: 12529099 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Treatment of refractory thrombotic thrombocytopenic purpura.

[No authors listed]

Ann Intern Med. 2003 Jan 21;138(2):I38. No abstract available. PMID: 12529111 [PubMed - indexed for MEDLINE]Related articlesFree article

Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.

Zheng X, Pallera AM, Goodnough LT, Sadler JE, Blinder MA.

Ann Intern Med. 2003 Jan 21;138(2):105-8.PMID: 12529092 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.

Hagel S, Jantsch J, Budde U, Kalden JR, Eckardt KU, Veelken R.

Thromb Haemost. 2008 Jul;100(1):151-3. No abstract available. PMID: 18612551 [PubMed - indexed for MEDLINE]Related articles

Rituximab for TTP.

Scott SM, Szczepiorkowski ZM.

Am J Hematol. 2005 Sep;80(1):87-8. No abstract available. PMID: 16138332 [PubMed - indexed for MEDLINE]Related articles

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.

Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP.

Blood. 2005 Sep 15;106(6):1932-7. Epub 2005 Jun 2.PMID: 15933059 [PubMed - indexed for MEDLINE]Related articlesFree article

Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.

Kosugi S, Matsumoto M, Ohtani Y, Take H, Ishizashi H, Fujimura Y, Kuyama J.

Int J Hematol. 2005 Jun;81(5):433-6. Review.PMID: 16158827 [PubMed - indexed for MEDLINE]Related articles

Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus.

Limal N, Cacoub P, Sène D, Guichard I, Piette JC.

Lupus. 2008;17(1):69-71. No abstract available. PMID: 18089688 [PubMed - indexed for MEDLINE]Related articles

[Thrombotic thrombocytopenic purpura, systemic lupus erythematosus and rescue treatment with cyclophosphamide]

Ramírez Duque N, García Morillo JS, Andreu Alvarez J, Martino Galiana ML.

Rev Clin Esp. 2005 Oct;205(10):520-2. Spanish. No abstract available. PMID: 16238970 [PubMed - indexed for MEDLINE]Related articles

Treatment of thrombotic thrombocytopenic purpura.

van der Straaten M, Jamart S, Wens R, Gottignies P, Dratwa M, Devriendt J.

Intensive Care Med. 2005 Apr;31(4):600. Epub 2005 Feb 10. No abstract available. PMID: 15703893 [PubMed - indexed for MEDLINE]Related articles

[Rituximab as treatment for thrombocytopenic thrombotic purpura associated with systemic lupus erythematosus]

López Carmona D, Pérez de Pedro I, de Ramón E, Camps García MT.

Med Clin (Barc). 2007 Dec 1;129(20):797-8. Spanish. No abstract available. PMID: 18093482 [PubMed - indexed for MEDLINE]Related articles

Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.

Herbei L, Venugopal P.

Clin Adv Hematol Oncol. 2006 Mar;4(3):215-7; discussion 217-8. No abstract available. PMID: 16728931 [PubMed - indexed for MEDLINE]Related articles

Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases.

Pérez-Sánchez I, Anguita J, Pintado T.

Ann Hematol. 1999 Jun;78(6):285-7.PMID: 10422632 [PubMed - indexed for MEDLINE]Related articles

Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.

Rüfer A, Brodmann D, Gregor M, Kremer Hovinga JA, Lämmle B, Wuillemin WA.

Swiss Med Wkly. 2007 Sep 22;137(37-38):518-24. Review.PMID: 17990141 [PubMed - indexed for MEDLINE]Related articlesFree article

A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura.

Foley SR, Webert K, Arnold DM, Rock GA, Clark WF, Barth D, Sutton DM; Members of the Canada Apheresis Group (CAG).

Kidney Int Suppl. 2009 Feb;(112):S55-8. Review.PMID: 19180138 [PubMed - indexed for MEDLINE]Related articles

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Sadler JE.

Blood. 2008 Jul 1;112(1):11-8. Review.PMID: 18574040 [PubMed - indexed for MEDLINE]Related articlesFree article

Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease.

Niewold TB, Alpert D, Scanzello CR, Paget SA.

J Rheumatol. 2006 Jun;33(6):1194-6.PMID: 16755668 [PubMed - indexed for MEDLINE]Related articles

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.

Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, Mackie I, Machin SJ.

Br J Haematol. 2007 Feb;136(3):451-61.PMID: 17233847 [PubMed - indexed for MEDLINE]Related articles

Immunotherapy for thrombotic thrombocytopenic purpura.

Cataland SR, Wu HM.

Curr Opin Hematol. 2005 Sep;12(5):359-63. Review.PMID: 16093780 [PubMed - indexed for MEDLINE]Related articles